In Vivo Proof of Concept of Adoptive Immunotherapy for Hepatocellular Carcinoma Using Allogeneic Suicide Gene-modified Killer Cells-Reference-Cited by-同舟云学术

In Vivo Proof of Concept of Adoptive Immunotherapy for Hepatocellular Carcinoma Using Allogeneic Suicide Gene-modified Killer Cells

Published:2014-03 Issue:3 Volume:22 Page:634-644
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Leboeuf Céline,Mailly Laurent,Wu Tao,Bour Gaetan,Durand Sarah,Brignon Nicolas,Ferrand Christophe,Borg Christophe,Tiberghien Pierre,Thimme Robert,Pessaux Patrick,Marescaux Jacques,Baumert Thomas F.,Robinet Eric

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference38 articles.

1. Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting;Thomas;J Clin Oncol,2010

2. Recent advances in the treatment of hepatocellular carcinoma;Padhya;Curr Opin Gastroenterol,2013

3. Diagnosis and treatment of hepatocellular carcinoma;El-Serag;Gastroenterology,2008

4. Adoptive T cell therapy of cancer;Brenner;Curr Opin Immunol,2010

5. Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia;Velardi;Curr Opin Immunol,2009

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric antigen receptor-modified cells for the treatment of solid tumors: First steps in a thousand-mile march;NK Cells in Cancer Immunotherapy: Successes and Challenges;2023

2. Association of Diabetes Mellitus and Alcohol Abuse with Cancer: Molecular Mechanisms and Clinical Significance;Cells;2021-11-08

3. Combination of natural killer cell-based immunotherapy and irreversible electroporation for the treatment of hepatocellular carcinoma;Annals of Translational Medicine;2021-07

4. Prospects and Challenges for T Cell-Based Therapies of HCC;Cells;2021-06-30

5. Atypical immunometabolism and metabolic reprogramming in liver cancer: Deciphering the role of gut microbiome;Advances in Cancer Research;2021